These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10771297)

  • 1. Endogenous renin and related short-term blood pressure variability in the conscious rat.
    Blanc J; Lambert G; Elghozi JL
    Eur J Pharmacol; 2000 Apr; 394(2-3):311-20. PubMed ID: 10771297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of isoprenaline infusion on renal renin and angiotensinogen gene expression in the anaesthetised rat.
    Moosavi SM; Johns EJ
    Exp Physiol; 2003 Mar; 88(2):221-7. PubMed ID: 12621527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats.
    Wood JM; Schnell CR; Levens NR
    Hypertension; 1993 Jun; 21(6 Pt 2):1056-61. PubMed ID: 8505092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin secretion in conscious Lyon hypertensive rats.
    Bertolino S; Julien C; Medeiros IA; Cuisinaud G; Vincent M; Barrès C
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1199-204. PubMed ID: 8945954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
    Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
    Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
    Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
    Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic leptin infusion increases arterial pressure.
    Shek EW; Brands MW; Hall JE
    Hypertension; 1998 Jan; 31(1 Pt 2):409-14. PubMed ID: 9453337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study.
    Basset A; Blanc J; Messas E; Hagège A; Elghozi JL
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):163-72. PubMed ID: 11209999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
    Goyal S; Bharti S; Sahoo KC; Sharma AK; Arya DS
    Cardiovasc Toxicol; 2011 Jun; 11(2):148-56. PubMed ID: 21380857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
    LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
    Reid IA; Bui H; Chou L
    Hypertension; 1994 Jan; 23(1 Suppl):I49-53. PubMed ID: 8282375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.